• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Lupin Limited — Updates, 14-11-2025: Press Release

    14-11-2025 | 07:16 am

    Lupin launched Risperidone extended-release injectable in the U.S. with 180-day market exclusivity. This is its first product from the PrecisionSphere™ platform, entering a market with estimated sales of USD 187 million.

    No comments yet. Be the first to comment!

    All announcements from Lupin Limited